Metlife earnings release, May 6, 2026

Metlife Inc (MET) · Form 8-K, Item 2.02 · Filed · SEC filing

Page 1 of 25

For Immediate Release | Global Communications | MetLife, Inc.

MetLife Announces 1Q 2026 Results

• Net income increased

30%¹ to

$1.1 billion, or

$1.74 per share.

• Adjusted earnings increased

18% to

$1.6 billion, driven by higher variable investment income, volume growth and favorable underwriting.

• Adjusted earnings per share increased

23% to

$2.42.

• Premiums, fees and other revenues (PFOs) increased

5% to

$14.3 billion.

• Adjusted PFOs, excluding pension risk transfers

(PRT), increased

10% to

$13.3 billion, with growth in all segments.

• Net investment income up

10% to

$5.4 billion.

• Variable investment income up

58% to

$518 million, driven by higher private equity returns.

• Book value per share (BVPS) up

8% to

$37.92, adjusted BVPS up

4% to

$57.41.

• Returned over $1.1 billion to shareholders via share repurchases and common stock dividends.

• Holding company cash and liquid assets totaled

$3.9 billion at quarter end, at top of target range.

• Group Benefits adjusted earnings up

19% to

$439 million primarily due to favorable life underwriting and volume growth.

• Retirement and Income Solutions adjusted earnings up

11% to

$451 million.

• Asia adjusted earnings up

31% to

$487 million.

• Latin America adjusted earnings up

5% to

$229 million.

• EMEA adjusted earnings up

33% to

$110 million.

• MetLife Investment Management adjusted earnings up

68% to

$47 million.

Earnings

Per Share

1Q 2026

Net

Income

$1.74

Adjusted

Earnings

$2.42

Return on Equity (ROE)

1Q 2026

ROE

18.2%

Adjusted

ROE

17.0%

Comment from Michel Khalaf, President and Chief Executive Officer:

MetLife delivered exceptional performance in the first quarter, with adjusted earnings per share up 23 percent and widespread top-line growth.

Our strong start to 2026 reflects how we're accelerating progress in year two of New

Frontier, supported by disciplined execution across the enterprise, and deliberate capital deployment that balances investment in our businesses with returning capital to shareholders.

We remain confident in delivering against the ambitious financial targets we laid out under New Frontier. By keeping customers at the center, we will continue to drive responsible growth and create long‑term shareholder value that consistently compounds over time.¹

In this news release, all comparisons of results for the first quarter of 2026 are with the first quarter of 2025, unless otherwise noted.

Page 2 of 25

First Quarter

2026

Summary

Information regarding the non-GAAP and other financial measures included in this news release and reconciliation of the non-GAAP financial measures to GAAP measures are in “Non-GAAP and Other Financial Disclosures” below and in the tables that accompany this news release.

Supplemental slides for the first quarter of

2026, titled “

1Q26

Earnings Call Presentation,” are available on the MetLife Investor Relations website at https://investor.metlife.com and in the

Form 8-K furnished by MetLife to the U.S. Securities and Exchange Commission in connection with this earnings release. Supplemental information about MetLife's diversified global investment portfolio is contained in the "

1Q26

- General Account Assets Under Management

Fact Sheet," available on the above-mentioned website.

Page 3 of 25

Total Company Discussion

Premiums, fees and other income were

$14.3 billion, up

5 percent compared with the prior- year quarter. Adjusted premiums, fees and other revenues, excluding pension risk transfers, were

$13.3 billion, up

10 percent.

Net investment income was

$5.4 billion, up

10 percent, primarily due to higher variable investment income and asset growth. Adjusted net investment income was

$5.5 billion, up⁵ percent, mainly driven by higher variable investment income.

Net investment losses were $

670 million, or

$529 million after tax, reflecting normal trading activity and a stable credit environment. Net derivative gains amounted to $

74 million, or

$

58 million after tax, driven by higher interest rates.

Net income was

$1.1 billion reflecting higher adjusted earnings, partially offset by certain investment-related items.

On a per-share basis, net income increased

36 percent to

$1.74.

Adjusted earnings were

$1.6 billion, up

18 percent on a reported basis and

15 percent on a constant currency basis. On a per-share basis, adjusted earnings were

$2.42, up

23 percent.

Direct expense ratio, excluding total notable items related to direct expenses and PRT, was

11.9 percent, compared to

12.0 percent in the prior-year quarter.

Page 4 of 25

Adjusted Earnings by Segment Summary

Business Discussions

GROUP BENEFITS

• Adjusted earnings were

$439 million, up

19 percent, primarily reflecting favorable life underwriting and volume growth.

• Adjusted PFOs were

$6.5 billion, up

2 percent. Overall growth was partially offset by the impact of participating contracts. PFOs from participating contracts can fluctuate with claims experience.

• Sales were up 15 percent, primarily driven by growth across both core and voluntary products.

RIS

• Adjusted earnings were

$451 million, up

11 percent, primarily driven by higher variable investment income and favorable underwriting.

• Adjusted PFOs were

$2.4 billion.

• Adjusted PFOs, excluding PRT, were

$1.5 billion, up

58 percent, reflecting growth across most products, led by U.K. longevity reinsurance, post-retirement benefits and structured settlements.

• Total retained liability exposure grew

3 percent, including

1 percent in retained general account liabilities.

Page 5 of 25

ASIA

• Adjusted earnings were

$487 million, up

31 percent on both a reported basis and a... (truncated)variable investment income and volume growth.

• Adjusted PFOs were

$1.7 billion, up

3 percent on a reported basis, and up

5 percent on a constant currency basis.

• Asia general account assets under management (at amortized cost) were

$140.7 billion, up

7 percent on a constant currency basis.

• Sales were

$766 million, up

22 percent on a constant currency basis, primarily driven by strong growth in Japan and Korea.

LATIN AMERICA

• Adjusted earnings were

$229 million, up

5 percent on a reported basis and down

9 percent on a constant currency basis, reflecting unfavorable tax-related items, including the impact of the Mexico value-added tax change, partially offset by volume growth and favorable underwriting.

• Adjusted PFOs were

$1.9 billion, up

25 percent on a reported basis and up

11 percent on a co nstant currency basis, due to strong growth and solid persistency across the region.

• Sales were

$521 million, up

20 percent on a constant currency bas is, driven by growth across the region.

EMEA

• Adjusted earnings were

$110 million, up

33 percent on a reported basis and 28 percent on a constant currency basis, primarily driven by strong volume growth.

• Adjusted PFOs were

$797 million, up

19 percent on a reported basis and up

15 percent on a constant currency basis, reflecting strong sales momentum and solid renewal activity across the region.

• Sales were

$370 million, up

17 percent on a constant currency basis.

Page 6 of 25

METLIFE INVESTMENT MANAGEMENT

• Adjusted earnings were

$47 million compared with

$28 million, driven by business growth and expense management.

• Other revenues were

$314 million, up

44 percent reflecting the acquisition of PineBridge

Investments.

• Total assets under management were

$736.3 billion, up

22 percent.

CORPORATE & OTHER

• Adjusted loss of

$177 million, compared to an adjusted loss of

$129 million.

INVESTMENTS

• Adjusted net investment income was

$5.5 billion, up

5 percent. Variable investment income increased

58 percent to

$518 million, primarily driven by higher returns on private equity assets.

FIRST QUARTER

2026 NOTABLE ITEMS

Page 7 of 25

Contacts:

For Media:

Steve LaMarca (646) 884-3840, Steve.LaMarca@metlife.com

For Investors:

John Hall (212) 578-7888, John.A.Hall@metlife.com

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

Conference Call

MetLife will hold its first quarter 2026 earnings conference call on Thursday, May 7, 2026, from

9-10 a.m. (ET) via a live webcast. Please click on the following link to register: https:// events.q4inc.com/attendee/313008777. A replay of the webcast will be available at investor.metlife.com for seven days following the call.

###

Page 8 of 25

Non-GAAP and Other Financial Disclosures

In this news release, MetLife presents certain measures of its performance on a consolidated and segment basis that are not calculated in accordance with accounting principles generally accepted in the

United States of America (GAAP). MetLife believes that these non-GAAP financial measures enhance our investors’ understanding of MetLife’s performance by highlighting the results of operations and the underlying profitability drivers of the business. Segment-specific financial measures are calculated using only the portion of consolidated results attributable to that specific segment.

The following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:

Page 9 of 25

Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are not accessible on a forward-looking basis because we believe it is not possible without unreasonable effort to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income (loss).

Any of these financial measures shown on a constant currency basis reflect the impact of changes in foreign currency exchange rates and are calculated using the average foreign currency exchange rates for the current period and applied to the comparable prior period (“constant currency basis”).

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this earnings news release and this period’s earnings materials, which are available at MetLife’s Investor Relations webpage (https://investor.metlife.com).

MetLife’s definitions of non-GAAP and other financial measures discussed in this news release may differ from those used by other companies:

Adjusted earnings and related measures

• adjusted earnings;

Page 10 of 25

• adjusted earnings available to common shareholders;

• adjusted earnings available to common shareholders, on a constant currency basis;

• adjusted earnings available to common shareholders, excluding total notable items;

• adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis;

• adjusted earnings available to common shareholders per diluted common share;

• adjusted earnings available to common shareholders, on a constant currency basis per diluted common share;

• ... (truncated)per diluted common share; and

• adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis per diluted common share.

Adjusted earnings is used by MetLife’s chief operating decision maker, its chief executive officer, to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, adjusted earnings is MetLife’s GAAP measure of segment performance. Adjusted earnings and related measures based on adjusted earnings are also the measures by which senior management’s and many other employees’ performance is evaluated for the purposes of determining their compensation under applicable compensation plans. Adjusted earnings and related measures based on adjusted earnings allow analysis of MetLife’s performance relative to its business plan and facilitate comparisons to industry results.

Adjusted earnings is defined as adjusted revenues less adjusted expenses, net of income tax. Adjusted earnings available to common shareholders is defined as adjusted earnings less preferred stock dividends.

Adjusted earnings, along with the related adjusted revenues, adjusted expenses and adjusted premiums, fees and other revenues, focus on our primary businesses principally by excluding the impact of (i) market volatility which could distort trends, (ii) asymmetrical and non-economic accounting, (iii) revenues and costs related to divested businesses, and (iv) other adjustments. Also, adjusted earnings and related measures exclude results of discontinued operations under GAAP.

Market volatility can have a significant impact on MetLife’s financial results. Adjusted earnings excludes net investment gains (losses), net derivative gains (losses), market risk benefit remeasurement gains

(losses) and goodwill impairments. Further, net investment income is adjusted to exclude similar items relating to joint ventures accounted for under the equity method (“Joint venture adjustments”), and policyholder benefits and claims exclude (i) changes in the discount rate on certain annuitization guarantees accounted for as additional liabilities and (ii) market value adjustments.

Asymmetrical and non-economic accounting adjustments are made in calculating adjusted earnings:

• Universal life and investment-type product policy fees exclude asymmetrical accounting associated with in-force reinsurance.

• Net investment income includes earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment hedge adjustments”).

• Other revenues include settlements of foreign currency earnings hedges and exclude asymmetrical accounting associated with in-force reinsurance.

• Policyholder benefits and claims excludes (i) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments, (ii) asymmetrical accounting associated with in- force reinsurance, and (iii) non-economic losses incurred at contract inception for certain single premium annuity business. These losses are amortized into adjusted earnings within policyholder benefits and claims over the estimated lives of the contracts.

• Policyholder liability remeasurement gains (losses) excludes asymmetrical accounting associated with in-force reinsurance.

Page 11 of 25

• Interest credited to policyholder account balances excludes amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass-through adjustments and asymmetrical accounting associated with in-force reinsurance.

“Divested businesses” are those that have been or will be sold or exited by MetLife but do not meet the discontinued operations criteria under GAAP. Divested businesses also include the net impact of transactions with exited businesses that have been eliminated in consolidation under GAAP and costs relating to businesses that have been or will be sold or exited by MetLife that do not meet the criteria to be included in results of discontinued operations under GAAP.

Other adjustments are made in calculating adjusted earnings:

• Beginning in the fourth quarter of 2025, net investment income excludes depreciation of wholly- owned real estate and real estate joint ventures.

• Net investment income and interest credited to policyholder account balances exclude certain amounts related to contractholder-directed equity securities (“Unit-linked contract income” and

“Unit-linked contract costs”).

• Net investment income and other expenses exclude Reinsurance activity (as defined below).

• Net investment income and interest expense on debt exclude amounts related to collateralized financing entities that are consolidated variable interest entities.

• Other revenues and other expenses exclude asset management distribution fees on funds that are passed through to distribution partners.

• Other revenues include fee revenue on synthetic guaranteed interest contracts (“GICs”) accounted for as freestanding derivatives.

• Other expenses exclude (i) amortization and impairment of asset management intangible assets,

(ii) implementation of new insurance regulatory requirements and other costs, and (iii) acquisition, integration and other related costs. Other expenses include (i) deductions for net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests, and (ii) benefits accrued on synthetic GICs accounted for as freestanding derivatives.

• “Reinsurance activity” relates to amounts subject to ceded reinsurance arrangements with third parties and joint ventures, including (i) the related investment returns and expenses which are passed through to the reinsurers and (ii) the corresponding invested assets and cash and cash equivalents.... (truncatings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.

The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from MetLife’s effective tax rate. Additionally, the provision for income tax

(expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms.

In addition, adjusted earnings available to common shareholders excludes the impact of preferred stock redemption premium, which is reported as a reduction to net income (loss) available to MetLife, Inc.’s common shareholders.

Investment portfolio gains (losses) and derivative gains (losses)

These are measures of investment and hedging activity. Investment portfolio gains (losses) principally excludes amounts that are reported within net investment gains (losses) but do not relate to the performance of the investment portfolio, such as gains (losses) on sales and divestitures of businesses, as well as investment portfolio gains (losses) of divested businesses. Derivative gains (losses) principally excludes earned income on derivatives and amortization of premium on derivatives, where such

Page 12 of 25 derivatives are either hedges of investments or are used to replicate certain investments, and where such derivatives do not qualify for hedge accounting. This earned income and amortization of premium is reported within adjusted earnings and not within derivative gains (losses).

Return on equity and related measures

• Total MetLife, Inc.’s adjusted common stockholders’ equity

: total MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), market risk benefits instrument-specific credit risk remeasurement gains (losses) and defined benefit plans adjustment components of accumulated other comprehensive income (loss) (“AOCI”) and the estimated fair value of certain ceded reinsurance-related embedded derivatives, all net of income tax.

• Total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items

: total

MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), market risk benefits instrument-specific credit risk remeasurement gains (losses) and defined benefit plans adjustment components of AOCI, the estimated fair value of certain ceded reinsurance-related embedded derivatives and total notable items, all net of income tax.

• Return on MetLife, Inc.’s common stockholders’ equity

: net income (loss) available to MetLife, Inc.’s common shareholders divided by MetLife, Inc.’s average common stockholders’ equity.

• Adjusted return on MetLife, Inc.’s common stockholders’ equity

: adjusted earnings available to common shareholders divided by MetLife, Inc.’s average adjusted common stockholders’ equity.

• Adjusted return on MetLife, Inc.’s common stockholders’ equity, excluding total notable items

: adjusted earnings available to common shareholders, excluding total notable items, divided by

MetLife, Inc.’s average adjusted common stockholders’ equity, excluding total notable items.

The above measures represent a level of equity that excludes most components of AOCI, such as unrealized investment gains (losses), net of related offsets, and future policy benefits discount rate remeasurement gains (losses), as well as the impact of certain ceded reinsurance-related embedded derivatives, as these amounts are primarily driven by market volatility.

Expense ratio, direct expense ratio, adjusted expense ratio and related measures

• Expense ratio

: other expenses, net of capitalization of DAC, divided by premiums, fees and other revenues.

• Direct expense ratio

: direct expenses divided by adjusted premiums, fees and other revenues. Direct expenses are comprised of employee-related costs, third-party staffing costs, and general and administrative expenses.

• Direct expense ratio, excluding total notable items related to direct expenses and PRT

: direct expenses, excluding total notable items related to direct expenses, divided by adjusted premiums, fees and other revenues, excluding PRT.

• Adjusted expense ratio

: adjusted other expenses, net of adjusted capitalization of DAC, divided by adjusted premiums, fees and other revenues.

• Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT

: adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses, divided by adjusted premiums, fees and other revenues, excluding PRT.

Assets Under Management (

“

AUM”):

• Total Assets Under Management (“Total AUM”) is comprised of MIM GA AUM plus Institutional Client

AUM (each, as defined below).

Page 13 of 25

• MIM General Account AUM (“MIM GA AUM”) is used by MetLife to describe the portion of GA AUM

(as defined below) that MetLife Investment Management, LLC and certain of its affiliates (“MIM”) manages or advises.

• General Account AUM (“GA AUM”) is used by MetLife to describe assets in its general account

(“GA”) investment portfolio. GA AUM is stated at estimated fair value and is comprised of GA total investments, the portion of the GA investment portfolio classified within assets held-for-sale, cash and cash equivalents, and accrued investment income on such assets, and excludes policy loans, certain contractholder-directed equity securities, fair value option securities, mortgage loans... (truncated)rd parties, assets subject to ceded reinsurance arrangements with third parties and joint ventures, and certain other invested assets. Mortgage loans and real estate and real estate joint ventures included in GA AUM (at net asset value, net of deduction for encumbering debt) have been adjusted from carrying value to estimated fair value. Classification of GA AUM by sector is based on the nature and characteristics of the underlying investments which can vary from how they are classified under GAAP. Accordingly, the underlying investments within certain real estate and real estate joint ventures that are primarily commercial mortgage loans (at net asset value, net of deduction for encumbering debt) have been reclassified to exclude them from real estate and real estate joint ventures and include them as commercial mortgage loans.

• Institutional Client AUM is comprised of SA AUM plus Reinsurance AUM plus TP AUM (each, as defined below). MIM manages or advises Institutional Client AUM in accordance with client guidelines contained in each investment advisory agreement.

◦ Separate Account AUM (“SA AUM”) is comprised of separate account investment portfolios, which are managed or advised by MIM and included in MetLife, Inc.’s consolidated financial statements at estimated fair value, as well as accrued investment income on such assets.

◦ Reinsurance AUM is comprised of GA assets subject to ceded reinsurance arrangements with third parties and joint ventures, which are managed or advised by MIM and are generally included in MetLife, Inc.’s consolidated financial statements at estimated fair value, as well as accrued investment income on such assets.

◦ Third-Party AUM (“TP AUM”) is comprised of non-proprietary assets managed or advised by MIM on behalf of unaffiliated/third-party clients, which are stated at estimated fair value, as well as accrued investment income on such assets. Such non-proprietary assets are owned by unaffiliated/third-party clients and, accordingly, are generally not included in MetLife, Inc.’s consolidated financial statements.

• Asia General Account AUM (“Asia GA AUM”) is used by MetLife to describe assets in its Asia GA investment portfolio. Asia GA AUM is stated at estimated fair value and is comprised of Asia GA total investments, the portion of the Asia GA investment portfolio classified within assets held-for-sale, cash and cash equivalents, and accrued investment income on such assets, and excludes policy loans, certain contractholder-directed equity securities, fair value option securities, mortgage loans originated for third parties, assets subject to ceded reinsurance arrangements with third parties and joint ventures, and certain other invested assets. Mortgage loans and real estate and real estate joint ventures included in Asia GA AUM (at net asset value, net of deduction for encumbering debt) have been adjusted from carrying value to estimated fair value. At the segment level, intersegment balances (intercompany activity, primarily related to investments in subsidiaries that eliminate at the

MetLife consolidated level) are excluded from Asia GA AUM.

Asia GA AUM (at amortized cost) excludes the following adjustments: (i) unrealized gain (loss) on investments carried at estimated fair value and (ii) adjustments from carrying value to estimated fair value on mortgage loans and real estate and real estate joint ventures. Asia GA AUM (at amortized cost) is presented net of related allowance for credit loss.

Other items

The following additional information is relevant to an understanding of MetLife’s performance:

Page 14 of 25

• Statistical sales information:

• Group Benefits: calculated using 10% of single premium deposits and 100% of annualized full- year premiums and fees from recurring premium policy sales of all products.

• RIS: calculated using 10% of single premium contracts, on and off-balance sheet deposits, and the contract value for new U.K. longevity reinsurance contracts, and 100% of annualized full-year premiums and fees only from recurring premium policy sales of specialized benefit resources and corporate-owned life insurance.

• Asia, Latin America and EMEA: calculated using 10% of single premium deposits (mainly from retirement products such as variable annuity, fixed annuity and pensions), 20% of single premium deposits from credit insurance and 100% of annualized full-year premiums and fees from recurring-premium policy sales of all products (mainly from risk and protection products such as individual life, accident & health and group).

Sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

• Volume growth, where cited, represents the change in certain measures of our segment results, including adjusted earnings, attributable to business growth, applying a model in which certain margins and factors are held constant, the most significant of which are underwriting margins, investment margins, changes in equity market performance, expense margins and the impact of changes in foreign currency exchange rates.

• PRT includes U.K. funded reinsurance.

• Institutional net flows reflect Institutional Client AUM total fund additions less withdrawals.

• “Third-party mortgage loan activity” relates to amounts associated with mortgage loans originated and acquired for third parties, including (i) the related investment returns and expenses which are passed through to the third-party lenders and (ii) the corresponding mortgage loan assets.

• We refer to observable forward yield curves as of a particular date in connection with making our estimates for future results. The observable forward yield curves at a given time are based on implied future interest rates along a range of interest rate durations. This includes the 10-year U.S.... (truncated)term interest rates used in our estimates for future results.

• Notable items reflect the unexpected impact of events that affect MetLife’s results, but that were unknown and that MetLife could not anticipate when it devised its business plan. Notable items also include certain items regardless of the extent anticipated in the business plan, to help investors have a better understanding of MetLife’s results and to evaluate and forecast those results. Notable items represent a positive (negative) impact to adjusted earnings available to common shareholders.

• Holding company cash and liquid assets are held by MetLife, Inc. collectively with other MetLife holding companies and include cash and cash equivalents, short-term investments and publicly traded securities excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include amounts received in connection with securities lending, repurchase agreements, derivatives, regulatory deposits, the collateral financing arrangement, funding agreements and secured borrowings, as well as amounts held in the closed block.

• MetLife uses a measure of free cash flow to facilitate an understanding of its ability to generate cash for reinvestment into its businesses or use in non-mandatory capital actions. MetLife defines free cash flow as the sum of cash available at MetLife’s holding companies from dividends from operating subsidiaries, expenses and other net flows of the holding companies (including capital contributions to subsidiaries), and net contributions from debt to be at or below target leverage ratios. This measure of free cash flow is prior to capital actions, such as common stock dividends and repurchases, debt reduction and mergers and acquisitions. Free cash flow should not be viewed as a substitute for net cash provided by (used in) operating activities calculated in accordance with

Page 15 of 25

GAAP. The free cash flow ratio is typically expressed as a percentage of annual adjusted earnings available to common shareholders.

Financial statements

Income Statement

March 31, 2026 (in millions)

For the Three Months EndedFor the Three Months EndedFor the Three Months EndedFor the Year-to-Date Period Ended
GAAP CONSOLIDATED STATEMENTS OF OPERATIONSUnaudited (In millions)March 31, 2025June 30, 2025September 30, 2025December 31, 2025March 31, 2026March 31, 2025March 31, 2026
RevenuesPremiums11,72310,81010,55516,69112,12011,72312,120
RevenuesUniversal life and investment-type product policy fees1,2291,2591,2471,2681,3431,2291,343
RevenuesNet investment income4,8855,6616,0895,9245,3554,8855,355
RevenuesOther revenues687679724737852687852
RevenuesNet investment gains (losses)-387-273-325-160-670-387-670
RevenuesNet derivative gains (losses)432-796-929-6467443274
RevenuesTotal revenues18,56917,34017,36123,81419,07418,56919,074
ExpensesPolicyholder benefits and claims11,80610,76710,36916,77611,86411,80611,864
ExpensesPolicyholder liability remeasurement (gains) losses-315-15935-13-31-13
ExpensesMarket risk benefit remeasurement (gains) losses299-277-263-267120299120
ExpensesInterest credited to policyholder account balances1,6472,4002,5612,3421,6741,6471,674
ExpensesPolicyholder dividends144146134129124144124
ExpensesAmortization of DAC, VOBA and negative VOBA519528522545568519568
ExpensesInterest expense on debt258269271263265258265
ExpensesOther expenses, net of capitalization of DAC2,5732,5222,7162,8742,9652,5732,965
ExpensesTotal expenses17,21516,36016,15122,69717,56717,21517,567
ExpensesIncome (loss) before provision for income tax1,3549801,2101,1171,5071,3541,507
ExpensesProvision for income tax expense (benefit)404245308301345404345
ExpensesNet income (loss)9507359028161,1629501,162
ExpensesLess: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests5667-235-23
ExpensesNet income (loss) attributable to MetLife, Inc.9457298968091,1859451,185
ExpensesLess: Preferred stock dividends66316631456645
ExpensesPreferred stock redemption premium12
ExpensesNet income (loss) available to MetLife, Inc.'s common shareholders8796988187781,1408791,140
ExpensesPremiums, fees and other revenues13,63912,74812,52618,69614,31513,63914,315

Income Statement

March 31, 2026

METLIFE CORPORATE OVERVIEW – For the Three Months Ended – March 31, 2025For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – June 30, 2025For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – September 30, 2025For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – December 31, 2025For the Three Months EndedMETLIFE CORPORATE OVERVIEW – For the Three Months Ended – March 31, 2026For the Three Months Ended
Net income (loss) available to MetLife, Inc.'s common shareholders8796988187781,140
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Net investment gains (losses)-387-273-325-160-670
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Net derivative gains (losses)432-796-929-64674
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Market risk benefit remeasurement gains (losses)-299277263267-120
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Other adjustments to net income (loss) (1)-234-6120-51477
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Provision for income tax (expense) benefit23195223190170
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Add: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests5667-23
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Add: Preferred stock redemption premium12
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Adjusted earnings available to common shareholders1,3491,3621,5841,6481,586
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Less: Total notable items (2)18-61
Adjustments from net income (loss) available to MetLife, Inc.'s common shareholders to adjusted earnings available to common shareholders:Adjusted earnings available to common shareholders, excluding total notable items (2)1,3491,3621,5661,7091,586

Income Statement

March 31, 2026

METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2025METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025METLIFE SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2026
Adjusted earnings before provision for income taxGROUP BENEFITS468508577589555
Adjusted earnings before provision for income taxRIS505460551563558
Adjusted earnings before provision for income taxASIA534489752625689
Adjusted earnings before provision for income taxLATIN AMERICA291317208270330
Adjusted earnings before provision for income taxEMEA109128115129143
Adjusted earnings before provision for income taxMIM3772788063
Adjusted earnings before provision for income taxCORPORATE & OTHER-102-141-100-86-192
Adjusted earnings before provision for income taxTotal adjusted earnings before provision for income tax1,8421,8332,1812,1702,146
Provision for income tax expense (benefit)GROUP BENEFITS98107121124116
Provision for income tax expense (benefit)RIS9990110109107
Provision for income tax expense (benefit)ASIA162143212181202
Provision for income tax expense (benefit)LATIN AMERICA72846072101
Provision for income tax expense (benefit)EMEA2628283233
Provision for income tax expense (benefit)MIM918202016
Provision for income tax expense (benefit)CORPORATE & OTHER-39-30-20-47-60
Provision for income tax expense (benefit)Total provision for income tax expense (benefit)427440531491515
Adjusted earnings available to common shareholdersGROUP BENEFITS370401456465439
Adjusted earnings available to common shareholdersRIS406370441454451
Adjusted earnings available to common shareholdersASIA372346540444487
Adjusted earnings available to common shareholdersLATIN AMERICA219233148198229
Adjusted earnings available to common shareholdersEMEA831008797110
Adjusted earnings available to common shareholdersMIM2854586047
Adjusted earnings available to common shareholdersCORPORATE & OTHER (1)-129-142-146-70-177
Adjusted earnings available to common shareholdersTotal adjusted earnings available to common shareholders (1)1,3491,3621,5841,6481,586

Income Statement

March 31, 2026

GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2025GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025GROUP BENEFITS STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – March 31, 2026March 31, 2025March 31, 2026
Adjusted revenuesPremiums5,7635,8015,6625,6325,8485,7635,848
Adjusted revenuesUniversal life and investment-type product policy fees233240227236230233230
Adjusted revenuesNet investment income353345356358352353352
Adjusted revenuesOther revenues434405417419461434461
Adjusted revenuesTotal adjusted revenues6,7836,7916,6626,6456,8916,7836,891
Adjusted expensesPolicyholder benefits and claims and policyholder dividends5,1835,1614,9824,8895,1475,1835,147
Adjusted expensesPolicyholder liability remeasurement (gains) losses-18-4-9-3-2-18-2
Adjusted expensesInterest credited to policyholder account balances72737371707270
Adjusted expensesCapitalization of DAC-5-7-7-7-6-5-6
Adjusted expensesAmortization of DAC, VOBA and negative VOBA677612612
Adjusted expensesInterest expense on debt111111
Adjusted expensesOther expenses1,0761,0521,0381,1001,1141,0761,114
Adjusted expensesTotal adjusted expenses6,3156,2836,0856,0566,3366,3156,336
Adjusted expensesAdjusted earnings before provision for income tax468508577589555468555
Adjusted expensesProvision for income tax expense (benefit)9810712112411698116
Adjusted expensesAdjusted earnings370401456465439370439
Adjusted expensesAdjusted earnings available to common shareholders370401456465439370439
Adjusted expensesLess: Total notable items-2
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items370401458465439370439
Adjusted expensesAdjusted premiums, fees and other revenues6,4306,4466,3066,2876,5396,4306,539

Income Statement

March 31, 2026

ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2025ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025ASIA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – March 31, 2026March 31, 2025March 31, 2026
Adjusted revenuesPremiums1,2601,2781,2901,2221,2941,2601,294
Adjusted revenuesUniversal life and investment-type product policy fees406399407428427406427
Adjusted revenuesNet investment income1,2041,2041,3741,4051,4611,2041,461
Adjusted revenuesOther revenues15222021171517
Adjusted revenuesTotal adjusted revenues2,8852,9033,0913,0763,1992,8853,199
Adjusted expensesPolicyholder benefits and claims and policyholder dividends1,0371,0511,0741,0101,0881,0371,088
Adjusted expensesPolicyholder liability remeasurement (gains) losses-11-12-1416-15-11-15
Adjusted expensesInterest credited to policyholder account balances711757804825833711833
Adjusted expensesCapitalization of DAC-351-418-435-413-465-351-465
Adjusted expensesAmortization of DAC, VOBA and negative VOBA216223207208211216211
Adjusted expensesOther expenses749813830815858749858
Adjusted expensesTotal adjusted expenses2,3512,4142,3392,4512,5102,3512,510
Adjusted expensesAdjusted earnings before provision for income tax534489752625689534689
Adjusted expensesProvision for income tax expense (benefit)162143212181202162202
Adjusted expensesAdjusted earnings372346540444487372487
Adjusted expensesAdjusted earnings available to common shareholders372346540444487372487
Adjusted expensesLess: Total notable items70
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items372346470444487372487
Adjusted expensesAdjusted premiums, fees and other revenues1,6811,6991,7171,6711,7381,6811,738

Income Statement

March 31, 2026

EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2025EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025EMEA STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – March 31, 2026March 31, 2025March 31, 2026
Adjusted revenuesPremiums582626638679689582689
Adjusted revenuesUniversal life and investment-type product policy fees78848298997899
Adjusted revenuesNet investment income58616668675867
Adjusted revenuesOther revenues89710989
Adjusted revenuesTotal adjusted revenues726780793855864726864
Adjusted expensesPolicyholder benefits and claims and policyholder dividends277309333334337277337
Adjusted expensesPolicyholder liability remeasurement (gains) losses43-133
Adjusted expensesInterest credited to policyholder account balances17202125211721
Adjusted expensesCapitalization of DAC-126-136-151-155-155-126-155
Adjusted expensesAmortization of DAC, VOBA and negative VOBA948885100979497
Adjusted expensesOther expenses355367387423418355418
Adjusted expensesTotal adjusted expenses617652678726721617721
Adjusted expensesAdjusted earnings before provision for income tax109128115129143109143
Adjusted expensesProvision for income tax expense (benefit)26282832332633
Adjusted expensesAdjusted earnings83100879711083110
Adjusted expensesAdjusted earnings available to common shareholders83100879711083110
Adjusted expensesLess: Total notable items-1
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items83100889711083110
Adjusted expensesAdjusted premiums, fees and other revenues668719727787797668797

Income Statement

March 31, 2026

MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2025MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025MIM STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – March 31, 2026March 31, 2025March 31, 2026
Adjusted revenuesNet investment income1212515
Adjusted revenuesOther revenues218237238239314218314
Adjusted revenuesTotal adjusted revenues219239239241319219319
Adjusted expensesInterest expense on debt11
Adjusted expensesOther expenses182167161161255182255
Adjusted expensesTotal adjusted expenses182167161161256182256
Adjusted expensesAdjusted earnings before provision for income tax37727880633763
Adjusted expensesProvision for income tax expense (benefit)918202016916
Adjusted expensesAdjusted earnings28545860472847

Income Statement

March 31, 2026

CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – March 31, 2025CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – June 30, 2025CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – September 30, 2025CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Three Months Ended – December 31, 2025CORPORATE & OTHER STATEMENTS OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS – For the Year-to-Date Period Ended – March 31, 2026March 31, 2025March 31, 2026
Adjusted revenuesPremiums666632632684592666592
Adjusted revenuesUniversal life and investment-type product policy fees68635537346834
Adjusted revenuesNet investment income9999791,0381,086953999953
Adjusted revenuesOther revenues-87-93-91-96-118-87-118
Adjusted revenuesTotal adjusted revenues1,6461,5811,6341,7111,4611,6461,461
Adjusted expensesPolicyholder benefits and claims and policyholder dividends1,2101,1711,1601,2021,1101,2101,110
Adjusted expensesPolicyholder liability remeasurement (gains) losses161646221622
Adjusted expensesInterest credited to policyholder account balances36353729273627
Adjusted expensesCapitalization of DAC-7-4-6-8-6-7-6
Adjusted expensesAmortization of DAC, VOBA and negative VOBA55525552495549
Adjusted expensesInterest expense on debt250260263256255250255
Adjusted expensesOther expenses188192221260196188196
Adjusted expensesTotal adjusted expenses1,7481,7221,7341,7971,6531,7481,653
Adjusted expensesAdjusted earnings before provision for income tax-102-141-100-86-192-102-192
Adjusted expensesProvision for income tax expense (benefit)-39-30-20-47-60-39-60
Adjusted expensesAdjusted earnings-63-111-80-39-132-63-132
Adjusted expensesPreferred stock dividends66316631456645
Adjusted expensesAdjusted earnings available to common shareholders-129-142-146-70-177-129-177
Adjusted expensesLess: Total notable items13-32
Adjusted expensesAdjusted earnings available to common shareholders, excluding total notable items-129-142-159-38-177-129-177
Adjusted expensesAdjusted premiums, fees and other revenues647602596625508647508
Adjusted expensesAdjusted earnings available to common shareholders attributed to business activities120115173146109120109

Income Statement

Appendix

APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – March 31, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – June 30, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – September 30, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – December 31, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Three Months Ended – March 31, 2026APPENDIX METLIFE RECONCILIATION DETAIL – For the Year-to-Date Period Ended – March 31, 2025APPENDIX METLIFE RECONCILIATION DETAIL – For the Year-to-Date Period Ended – March 31, 2026
Reconciliation to Adjusted Earnings Available to Common ShareholdersNet income (loss) available to MetLife, Inc.'s common shareholders8796988187781,1408791,140
Reconciliation to Adjusted Earnings Available to Common ShareholdersAdd: Preferred stock dividends66316631456645
Reconciliation to Adjusted Earnings Available to Common ShareholdersAdd: Preferred stock redemption premium12
Reconciliation to Adjusted Earnings Available to Common ShareholdersAdd: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests5667-235-23
Reconciliation to Adjusted Earnings Available to Common ShareholdersNet income (loss)9507359028161,1629501,162
Less: adjustments from net income (loss) to adjusted earnings:Net investment gains (losses)-387-273-325-160-670-387-670
Less: adjustments from net income (loss) to adjusted earnings:Net derivative gains (losses)432-796-929-6467443274
Less: adjustments from net income (loss) to adjusted earnings:Market risk benefit remeasurement gains (losses)-299277263267-120-299-120
Less: adjustments from net income (loss) to adjusted earnings:Premiums - Divested businesses4314
Universal life and investment-type product policy feesAsymmetrical and non-economic accounting62525
Net investment incomeInvestment hedge adjustments-103-102-100-105-84-103-84
Net investment incomeJoint venture adjustments-4216-8-6418-4218
Net investment incomeDepreciation of wholly-owned real estate and real estate joint ventures (1)-72-61-61
Net investment incomeUnit-linked contract income-227498580366-318-227-318
Net investment incomeReinsurance activity434717722230143301
Net investment incomeDivested businesses11

Income Statement

Three Months Ended March 31, — Summary ($ in millions, except per share data)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025Three Months Ended March 31, – Change
Premiums, fees and other revenues14,31513,6395.0%
Net investment income5,3554,88510.0%
Net investment gains (losses)-670-387
Net derivative gains (losses)74432
Total revenues19,07418,569
Adjusted premiums, fees and other revenues14,18313,6144.0%
Adjusted premiums, fees and other revenues, excluding pension risk transfers (PRT)13,34012,13810.0%
Market risk benefit remeasurement gains (losses)-120-299
Net income (loss)1,14087930.0%
Net income (loss) per share1.741.2836.0%
Adjusted earnings1,5861,34918.0%
Adjusted earnings per share2.421.9623.0%
Adjusted earnings, excluding total notable items1,5861,34918.0%
Adjusted earnings, excluding total notable items per share2.421.9623.0%
Book value per share37.9235.168.0%
Adjusted book value per share57.4155.014.0%
Expense ratio20.7%18.9%
Direct expense ratio, excluding total notable items related to direct expenses and PRT11.9%12.0%
Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT20.3%20.6%
ROE18.2%14.9%
Adjusted ROE17.0%14.4%
Adjusted ROE, excluding total notable items17.0%14.4%

Income Statement

Page 17 of 25 (in millions)

MetLife, Inc. – GAAP Consolidated Statements of Operations – For the Three Months Ended – March 31, – 2026MetLife, Inc. – GAAP Consolidated Statements of Operations – For the Three Months Ended – March 31, – 2025
RevenuesPremiums12,12011,723
RevenuesUniversal life and investment-type product policy fees1,3431,229
RevenuesNet investment income5,3554,885
RevenuesOther revenues852687
RevenuesNet investment gains (losses)-670-387
RevenuesNet derivative gains (losses)74432
RevenuesTotal revenues19,07418,569
ExpensesPolicyholder benefits and claims11,86411,806
ExpensesPolicyholder liability remeasurement (gains) losses-13-31
ExpensesMarket risk benefit remeasurement (gains) losses120299
ExpensesInterest credited to policyholder account balances1,6741,647
ExpensesPolicyholder dividends124144
ExpensesAmortization of DAC, VOBA and negative VOBA568519
ExpensesInterest expense on debt265258
ExpensesOther expenses, net of capitalization of DAC2,9652,573
ExpensesTotal expenses17,56717,215
ExpensesIncome (loss) before provision for income tax1,5071,354
ExpensesProvision for income tax expense (benefit)345404
ExpensesNet income (loss)1,162950
ExpensesLess: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests-235
ExpensesNet income (loss) attributable to MetLife, Inc.1,185945
ExpensesLess: Preferred stock dividends4566
ExpensesNet income (loss) available to MetLife, Inc.'s common shareholders1,140879

Income Statement

Page 18 of 25 (In millions, except per share data)

MetLife, Inc. – For the Three Months Ended – March 31, – 2026MetLife, Inc. – For the Three Months Ended – March 31, – 2026 – Earnings Per Weighted Average Common Share Diluted (1)MetLife, Inc. – For the Three Months Ended – March 31, – 2025MetLife, Inc. – For the Three Months Ended – March 31, – 2025 – Earnings Per Weighted Average Common Share Diluted (1)
Net income (loss) available to MetLife, Inc.'s common shareholders1,1401.748791.28
Adjustments from net income (loss) available to common shareholders to adjusted earnings available to common shareholders:Less: Net investment gains (losses)-670-1.02-387-0.56
Adjustments from net income (loss) available to common shareholders to adjusted earnings available to common shareholders:Net derivative gains (losses)740.114320.63

Income Statement

Page 19 of 25 (in millions)

MetLife, Inc. – For the Three Months Ended – March 31, – 2026MetLife, Inc. – For the Three Months Ended – March 31, – 2025
Premiums, Fees and Other RevenuesPremiums, fees and other revenues14,31513,639
Less: Adjustments to premiums, fees and other revenues:Asymmetrical and non-economic accounting13236
Less: Adjustments to premiums, fees and other revenues:Other-15
Less: Adjustments to premiums, fees and other revenues:Divested businesses4
Less: Adjustments to premiums, fees and other revenues:Adjusted premiums, fees and other revenues14,18313,614
Less: Adjustments to premiums, fees and other revenues:Adjusted premiums, fees and other revenues, on a constant currency basis14,18313,813
Less: Adjustments to premiums, fees and other revenues:Less: PRT8431,476
Less: Adjustments to premiums, fees and other revenues:Adjusted premiums, fees and other revenues, excluding PRT, on a constant currency basis13,34012,337
Net Investment IncomeNet investment income5,3554,885
Less: Adjustments to net investment income:Investment hedge adjustments-84-103
Less: Adjustments to net investment income:Depreciation of wholly-owned real estate and real estate joint ventures-61
Less: Adjustments to net investment income:Joint venture adjustments18-42
Less: Adjustments to net investment income:Unit-linked contract income-318-227
Less: Adjustments to net investment income:Reinsurance activity30143
Less: Adjustments to net investment income:Divested businesses1
Less: Adjustments to net investment income:Adjusted net investment income5,4995,213
Revenues and ExpensesTotal revenues19,07418,569
Less: Adjustments to total revenues:Net investment gains (losses)-670-387
Less: Adjustments to total revenues:Net derivative gains (losses)74432
Less: Adjustments to total revenues:Investment hedge adjustments-84-103
Less: Adjustments to total revenues:Depreciation of wholly-owned real estate and real estate joint ventures-61
Less: Adjustments to total revenues:Asymmetrical and non-economic accounting, excluding Investment hedge adjustments13236
Less: Adjustments to total revenues:Unit-linked contract costs-318-227
Less: Adjustments to total revenues:Reinsurance activity30143
Less: Adjustments to total revenues:Other18-57
Less: Adjustments to total revenues:Divested businesses5
Less: Adjustments to total revenues:Total adjusted revenues19,68218,827
Less: Adjustments to total revenues:Total expenses17,56717,215
Less: Adjustments to total expenses:Market risk benefit remeasurement (gains) losses120299
Less: Adjustments to total expenses:Asymmetrical and non-economic accounting24139
Less: Adjustments to total expenses:Market volatility-74-44
Less: Adjustments to total expenses:Unit-linked contract costs-302-234
Less: Adjustments to total expenses:Reinsurance activity20542
Less: Adjustments to total expenses:Other5319
Less: Adjustments to total expenses:Divested businesses59
Less: Adjustments to total expenses:Total adjusted expenses17,53616,985

Balance Sheet

March 31, 2026 (in millions)

METLIFE GAAP CONSOLIDATED BALANCE SHEETSUnaudited (In millions)March 31, 2025June 30, 2025September 30, 2025December 31, 2025March 31, 2026
Investments:Fixed maturity securities available-for-sale, at estimated fair value291,735298,737304,645315,931316,110
Investments:Equity securities, at estimated fair value747790788858927
Investments:Contractholder-directed equity securities and fair value option securities, at estimated fair value10,72511,69412,27013,95913,435
Investments:Mortgage loans87,90886,86885,84384,59383,726
Investments:Policy loans8,6638,6648,5898,5478,455

Balance Sheet

March 31, 2026

RIS – FUTURE POLICY BENEFITS (1) – March 31, 2025RIS – FUTURE POLICY BENEFITS (1) – June 30, 2025RIS – FUTURE POLICY BENEFITS (1) – September 30, 2025RIS – FUTURE POLICY BENEFITS (1) – December 31, 2025RIS – FUTURE POLICY BENEFITS (1) – March 31, 2026
Balance, end of period (at balance sheet discount rate) (2)73,41573,50674,26384,98884,300
Less: Accumulated other comprehensive (income) loss-2,627-2,366-1,209-1,732-2,968
Balance, end of period (at original discount rate)76,04275,87275,47286,72087,268
Future policyholder benefits subject to reinsurance (at balance sheet discount rate) (2)2,2872,2667,75012,78612,503
Add: Accumulated other comprehensive (income) loss-16-27-149-63116
Balance, end of period (at original discount rate)2,2712,2397,60112,72312,619
POLICYHOLDER ACCOUNT BALANCESUnaudited (In millions)March 31, 2025June 30, 2025September 30, 2025December 31, 2025March 31, 2026
POLICYHOLDER ACCOUNT BALANCESBalance, end of period90,24392,19792,29193,54996,115
POLICYHOLDER ACCOUNT BALANCESPolicyholder account balances subject to reinsurance3,3274,2974,571
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES GENERAL ACCOUNT RETAINED BALANCES (3)Unaudited (In millions)March 31, 2025June 30, 2025September 30, 2025December 31, 2025March 31, 2026
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES GENERAL ACCOUNT RETAINED BALANCES (3)Balance, end of period164,014165,830156,835163,249166,193
TOTAL LIABILITIESUnaudited (In millions)March 31, 2025June 30, 2025September 30, 2025December 31, 2025March 31, 2026
TOTAL LIABILITIESGeneral account retained balances (3)164,014165,830156,835163,249166,193
TOTAL LIABILITIESSeparate account liabilities55,95354,86455,67157,12856,089
TOTAL LIABILITIESSynthetic GICS (4), (5)53,79653,74051,92052,66452,257
TOTAL LIABILITIESLongevity Reinsurance (6)27,36930,08729,29337,02536,440
TOTAL LIABILITIESTotal liability exposure retained, end of period301,132304,521293,719310,066310,979
TOTAL LIABILITIESTotal liability exposure, end of period303,403306,760304,647327,086328,169
Full release

Forward-Looking Statements

This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements give expectations or forecasts of future events and do not relate strictly to historical or current facts. They use words and terms such as “anticipate,” “are confident,” “assume,”

“believe,” “continue,” “could,” “estimate,” “expect,” “if,” “intend,” “likely,” “may,” “plan,” “potential,” “project,”

“should,” “target,” “will,” “would,” and other words and terms of similar meaning or that are otherwise tied to future periods or future performance, in each case in all derivative forms. They include statements relating to strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. By their nature, forward-looking statements: speak only as of the date they are made; are not statements of historical fact or guarantees of future performance; and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them.

However, there can be no assurance that management’s expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.

Many factors determine the results of MetLife, Inc., its subsidiaries and affiliates, and they involve unpredictable risks and uncertainties. Our forward-looking statements depend on our assumptions, our expectations, and our understanding of the economic environment, but they may be inaccurate and may change. MetLife, Inc. does not guarantee any future performance. Our results could differ materially from those MetLife, Inc. expresses or implies in forward-looking statements. The risks, uncertainties and other factors identified in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission, and others, may cause such differences. These factors include:

(1) economic condition difficulties, including risks relating to interest rates, the effects of announced or future tariff increases on the global economy, credit spreads, declining equity or debt markets, changes in the value of assets under management, real estate, obligors and counterparties, government default or shutdown, currency exchange rates, derivatives, climate change, public health, terrorism and security;

(2) global capital and credit market adversity;

(3) credit facility inaccessibility;

(4) financial strength or credit ratings downgrades;

(5) unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from reinsurers’ credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks;

(6) statutory life insurance reserve financing costs or limited market capacity;

(7) legal, regulatory, and supervisory and enforcement policy changes;

(8) changes in tax rates, tax laws or interpretations;

(9) litigation and regulatory investigations;

(10) unsuccessful efforts to meet all sustainability standards or to enhance our sustainability;

(11)

MetLife, Inc.’s inability to pay dividends and repurchase common stock;

(12)

MetLife, Inc.’s subsidiaries’ inability to pay dividends to MetLife, Inc.;

(13) investment defaults, downgrades, or volatility;

(14) investment sales or lending difficulties;

(15) collateral or derivative-related payments;

(16) investment valuations, allowances, or impairments changes;

(17)... (truncated)stimates, assumptions, or models;

(18) global political, legal, or operational risks;

(19) business competition;

Page 16 of 25

(20) technological changes;

(21) catastrophes;

(22) climate changes or responses to it;

(23) deficiencies in our closed block;

(24) goodwill or other asset impairment, or deferred income tax asset allowance;

(25) impairment of value of business acquired ("VOBA"), value of distribution agreements acquired or value of customer relationships acquired;

(26) product guarantee volatility, costs, and counterparty risks;

(27) risk management failures;

(28) insufficient protection from operational risks;

(29) failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or disaster recovery failures;

(30) accounting standards changes;

(31) excessive risk-taking;

(32) marketing and distribution difficulties;

(33) pension and other postretirement benefit assumption changes;

(34) inability to protect our intellectual property or avoid infringement claims;

(35) acquisition, integration, growth, disposition, or reorganization difficulties;

(36)

Brighthouse Financial, Inc. separation risks;

(37)

MetLife, Inc.’s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; and

(38) legal- and corporate governance-related effects on business combinations.

MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in subsequent reports to the U.S.

Securities and Exchange Commission.

Page 17 of 25

Page 18 of 25

Page 19 of 25

Page 20 of 25

Page 21 of 25

Page 22 of 25

Page 23 of 25

Page 24 of 25

Page 25 of 25

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Metlife earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.